News Daily News Platelet Reactivity High in Most Patients Who Develop Stent Thrombosis L.A. McKeown December 20, 2017
News Conference News AHA 2017 ‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18 Michael O'Riordan November 15, 2017
Presentation TCT 2017 Switching to and From Cangrelor: When and How? Presenter: Dominick J. Angiolillo, Marco Valgimigli October 30, 2017
Presentation TCT 2017 Why I Use Cangrelor for Primary PCI in STEMI! Presenter: Michael S. Lee, Dirk Sibbing, Dmitriy N. Feldman October 30, 2017
News Conference News TCT 2017 Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors Todd Neale October 30, 2017
News Conference News ESC 2017 Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI Shelley Wood September 01, 2017
News Conference News ESC 2017 P2Y12 Inhibitor Pretreatment Questioned in STEMI Todd Neale August 29, 2017
News Conference News ESC 2017 ESC Updates Guidelines for Treating STEMI Patients Michael O'Riordan August 27, 2017
News Daily News Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin Todd Neale March 07, 2017